Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARRIER GLOBAL CorpCARR · Entity 3043 | Senior VP & CLO | November 06, 2024 | November 08, 2024 |
| Encompass Health CorpEHC · Entity 3460 | Director | July 15, 2026 | July 16, 2026 |
| LOCKHEED MARTIN CORPLMT · Entity 2882 | SVP & General Counsel | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARRIER GLOBAL Corp
Report date November 06, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,083 |
Ending reported balance
After 2024-11-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-11-06 · Exercise / conversion · Acquired 217,150 · Balance 263,233 F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Row 2 · 2024-11-06 · Exercise / conversion · Acquired 32,000 · Balance 295,233 F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Row 3 · 2024-11-06 · Tax withholding · Disposed 81,967 · Balance 213,266 Row 4 · 2024-11-06 · Sale · Disposed 167,183 · Balance 46,083 F2: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $73.00 to $73.93 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.60 · Expires 2030-01-01 | Direct | 0 |
Reported balance
After 2024-11-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-11-06 · Exercise / conversion · Disposed 217,150 · Balance 0 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $16.55 · Expires 2030-05-13 | Direct | 78,200 |
Reported balance
After 2024-11-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-11-06 · Exercise / conversion · Disposed 32,000 · Balance 78,200 |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
F2: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $73.00 to $73.93 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Encompass Health Corp
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 11,582 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 19 · Balance 11,582 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.
LOCKHEED MARTIN CORP
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,719 |
Ending reported balance
After 2026-02-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-26 · Exercise / conversion · Acquired 5,285 · Balance 5,285 F1: Each restricted stock unit granted on February 26, 2025, was the economic equivalent of one share of LMT common stock. Row 2 · 2026-02-26 · Tax withholding · Disposed 2,566 · Balance 2,719 F2: Disposition to the Issuer of shares to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of stock units which is exempt under Rule 16b-3. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-02-25 | Direct | 1,992 |
Reported balance
After 2026-02-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-25 · Grant · Acquired 1,992 · Balance 1,992 F4: Each restricted stock unit represents a contingent right to receive one share of LMT common stock. F5: Award of restricted stock units which vests on the third anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2028-02-26 | Direct | 13,289 |
Reported balance
After 2026-02-26 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-26 · Exercise / conversion · Disposed 5,285 · Balance 13,289 F6: Restricted stock units convert to common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | IndirectLockheed Martin Salaried Savings Plan | 36.9851 |
Reported balance
Holding disclosure · report date 2026-02-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 36.9851 F3: Holdings as of reportable transaction date include additional acquisitions and dividend reinvestment under the company's 401(k) plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit granted on February 26, 2025, was the economic equivalent of one share of LMT common stock.
F2: Disposition to the Issuer of shares to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of stock units which is exempt under Rule 16b-3.
F3: Holdings as of reportable transaction date include additional acquisitions and dividend reinvestment under the company's 401(k) plan.
F4: Each restricted stock unit represents a contingent right to receive one share of LMT common stock.
F5: Award of restricted stock units which vests on the third anniversary of the grant date.
F6: Restricted stock units convert to common stock on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2023 Filed Jan 3, 2023 21:42 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | Exercise / conversionRestricted Stock Unit RSU · Derivative | 40,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000068 · doc4.xml · derivative · entry 3 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,471 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. F2 · derivative.expiration_date: The Expiration Date is January 2, 2023 Read SEC document |
| January 02, 2023 Filed Jan 3, 2023 21:42 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | Tax withholdingCommon Stock | 12,487 | $41.25 | $515,088.75 |
DisclosureSEC source: 0001225208-23-000068 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,500 Read SEC document |
| January 02, 2023 Filed Jan 3, 2023 21:42 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | Exercise / conversionCommon Stock | 40,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000068 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 15:11 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-024120 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,961 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 21:07 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019601 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 06, 2022 Filed May 9, 2022 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | PurchaseEncompass Health Common Stock | 1,000 | $66.48 | $66,480.00 |
DisclosureSEC source: 0001127602-22-013833 · form4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,436 Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013833 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,436 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 18:03 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012251 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:05 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 209 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-010702 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 23:04 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | GrantStock Appreciation Right · Derivative | 75,425 | $0.00 Strike: $47.51 | $0.00 |
DisclosureSEC source: 0001225208-22-001522 · doc4.xml · derivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,425 Underlying: Common Stock · 75,425 shares Expires 2032-02-01 F1 · balance_after: The reporting person was also awarded 17,075 Performance Share Units (PSUs) under the Carrier Global Corporation 2020 Long-Term Incentive Plan. Each PSU represents a contingent right to receive one share of Carrier Global Corporation common stock. The PSUs vest on the third anniversary of the grant date contingent upon (a) the reporting person's continued employment and (b) Carrier's achievement of pre-established performance targets for earnings per share growth and total shareowner return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 21:44 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | GrantStock Appreciation Right · Derivative | 83,175 | $38.33 Strike: $38.33 | $3,188,097.75 |
DisclosureSEC source: 0001225208-21-001853 · doc4.xml · derivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,175 Underlying: Common Stock · 83,175 shares Expires 2031-02-03 F1 · balance_after: The reporting person was also awarded 21,475 Performance Share Units (PSUs) under the Carrier Global Corporation Long-Term Incentive Plan. Each PSU has a value equal to one share of Carrier common stock and will only vest if Carrier achieves pre-established performance targets for earnings per share growth and total shareowner return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. Read SEC document |
| May 27, 2020 Filed Jun 23, 2020 20:09 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | SaleCommon Stock | 7.4647 | $19.99 | $149.22 |
DisclosureSEC source: 0001225208-20-009159 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior Vice President & CLO 10b5-1 filing: Not disclosed Ownership: Indirect · By UTC Savings Plan Trustee Disclosed balance after: 0 F1 · price: The reporting person held a small number of Carrier shares in the United Technologies Corporation (UTC) Savings Plan that resulted from Carrier's spinoff from UTC on April 3, 2020. That small sum of shares were inadvertently sold in the course of rolling over the reporting person's holdings in the UTC Savings Plan into his account with an investment firm. Read SEC document |
| May 14, 2020 Filed May 18, 2020 22:02 UTC | CARRIER GLOBAL Corp CARR · Entity 3043 | GrantStock Appreciation Right · Derivative | 110,200 | $16.55 Strike: $16.55 | $1,823,810.00 |
DisclosureSEC source: 0001225208-20-007967 · doc4.xml · derivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · VP, Chief Legal OfFicer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,200 Underlying: Common Stock · 110,200 shares Expires 2030-05-13 F1 · balance_after: The reporting person was also awarded 30,830 Performance Share Units (PSUs) under the Carrier Global Corporation 2020 Long-Term Incentive Plan. This award, like the award of the Stock Appreciation Rights, was part of a founder's grant awarded to the reporting person and to certain other executive officers and certain other employees. Each PSU has a value equal to one share of Carrier common stock and will only vest if Carrier achieves pre-established performance targets for Carrier's total shareholder return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.